SMSPHARMA / NSE / Biotechnology & Drugs
SMS Pharmaceuticals
1Y Price Trend
Key Information
Recommendations
Target High446.5
Target Low208.2
Target Mean0
Target Median0
Risk Metrics
Overall RiskHigh risk
Board Risk49.45
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Stocks to watch: One 97 Communications, Wipro, to KEC International and Bharat Electronics (BEL) — Here is a list of 10 company shares which will be in focus of the stock market investors on Monday, 15 December 2025.
SMS Pharmaceuticals shares rose nearly 17% after USFDA approved reformulated Ranitidine tablets from VKT Pharma. The approval, following safety assessments, marks the return of a key acid-reducing medication to the US market, enhancing patient access to vital treatments.
© SharekeyX | Rusaka Technologies 2024-2026

